Literature DB >> 19297606

Targeted delivery of hepatitis C virus-specific short hairpin RNA in mouse liver using Sendai virosomes.

Nithya Subramanian1, Prashant Mani2, Swagata Roy1, Sivakumar Vadivel Gnanasundram1, Debi P Sarkar2, Saumitra Das1.   

Abstract

Internal ribosome entry site (IRES)-mediated translation of input viral RNA is the initial required step for the replication of the positive-stranded genome of hepatitis C virus (HCV). We have shown previously the importance of the GCAC sequence near the initiator AUG within the stem and loop IV (SLIV) region in mediating ribosome assembly on HCV RNA. Here, we demonstrate selective inhibition of HCV-IRES-mediated translation using short hairpin (sh)RNA targeting the same site within the HCV IRES. sh-SLIV showed significant inhibition of viral RNA replication in a human hepatocellular carcinoma (Huh7) cell line harbouring a HCV monocistronic replicon. More importantly, co-transfection of infectious HCV-H77s RNA and sh-SLIV in Huh7.5 cells successfully demonstrated a significant decrease in viral RNA in HCV cell culture. Additionally, we report, for the first time, the targeted delivery of sh-SLIV RNA into mice liver using Sendai virosomes and demonstrate selective inhibition of HCV-IRES-mediated translation. Results provide the proof of concept that Sendai virosomes could be used for the efficient delivery of shRNAs into liver tissue to block HCV replication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19297606     DOI: 10.1099/vir.0.010579-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Re-analysis of cryoEM data on HCV IRES bound to 40S subunit of human ribosome integrated with recent structural information suggests new contact regions between ribosomal proteins and HCV RNA.

Authors:  Agnel Praveen Joseph; Prasanna Bhat; Saumitra Das; Narayanaswamy Srinivasan
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

2.  Targeting ribosome assembly on the HCV RNA using a small RNA molecule.

Authors:  Prasanna Bhat; Sivakumar Vadivel Gnanasundram; Prashant Mani; Partho Sarothi Ray; Debi P Sarkar; Saumitra Das
Journal:  RNA Biol       Date:  2012-08-01       Impact factor: 4.652

Review 3.  Stem cell-based anti-HIV gene therapy.

Authors:  Scott G Kitchen; Saki Shimizu; Dong Sung An
Journal:  Virology       Date:  2011-01-17       Impact factor: 3.616

4.  Inhibition of the interaction between NS3 protease and HCV IRES with a small peptide: a novel therapeutic strategy.

Authors:  Upasana Ray; Chaitrali L Roy; Anuj Kumar; Prashant Mani; Agnel P Joseph; G Sudha; Debi P Sarkar; N Srinivasan; Saumitra Das
Journal:  Mol Ther       Date:  2012-08-21       Impact factor: 11.454

5.  Long-term reduction of jaundice in Gunn rats by nonviral liver-targeted delivery of Sleeping Beauty transposon.

Authors:  Xia Wang; Debi P Sarkar; Prashant Mani; Clifford J Steer; Yong Chen; Chandan Guha; Voshavar Chandrasekhar; Arabinda Chaudhuri; Namita Roy-Chowdhury; Betsy T Kren; Jayanta Roy-Chowdhury
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

6.  Catalytic metallodrugs based on the LaR2C peptide target HCV SLIV IRES RNA.

Authors:  Martin James Ross; Seth S Bradford; J A Cowan
Journal:  Dalton Trans       Date:  2015-11-19       Impact factor: 4.390

7.  Reciprocal regulation of AKT and MAP kinase dictates virus-host cell fusion.

Authors:  Nishi R Sharma; Prashant Mani; Neha Nandwani; Rajakishore Mishra; Ajay Rana; Debi P Sarkar
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

8.  EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex.

Authors:  Nithya Subramanian; Jagat R Kanwar; Prasanna Kumar Athalya; Narayanan Janakiraman; Vikas Khetan; Rupinder K Kanwar; Sailaja Eluchuri; Subramanian Krishnakumar
Journal:  J Biomed Sci       Date:  2015-01-09       Impact factor: 8.410

9.  Polypyrimidine tract-binding protein (PTB) and PTB-associated splicing factor in CVB3 infection: an ITAF for an ITAF.

Authors:  Pratik Dave; Biju George; Divya Khandige Sharma; Saumitra Das
Journal:  Nucleic Acids Res       Date:  2017-09-06       Impact factor: 16.971

Review 10.  Exploring Internal Ribosome Entry Sites as Therapeutic Targets.

Authors:  Anton A Komar; Maria Hatzoglou
Journal:  Front Oncol       Date:  2015-10-20       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.